Browse 5 patentability of diagnostic and treatment methods cases decided by Federal Circuit. AI-powered summaries, holdings, and legal analysis.
Federal Circuit: Method using non-nucleic acid probe not patentable
Cash v. Collins, decided by Federal Circuit on February 5, 2026, resulted in a defendant win outcome. The case concerns the patentability of a method for detecting and quantifying nucleic acids using ...
Federal Circuit Affirms Patent Invalidity for Abstract Idea in Medical Treatment
Hamill v. Collins, decided by Federal Circuit on February 4, 2026, resulted in a defendant win outcome. The case concerns the patentability of a method for treating a patient with a specific genetic m...
Federal Circuit Affirms PTAB's Rejection of Patent for Abstract Idea
Beacon Point Associates LLC v. DVA, decided by Federal Circuit on June 5, 2025, resulted in a defendant win outcome. The case concerns whether a patent for a "method of treating a patient" was properl...
CAFC Affirms PTAB, Finds Drug Dosage Method Unpatentable Under § 101
Amezquita v. Collins, decided by Federal Circuit on May 5, 2025, resulted in a defendant win outcome. The case concerns the patentability of a method for treating a patient's condition using a specifi...
Federal Circuit: Off-label drug use methods not patentable under § 101
In Re RIGGS, decided by Federal Circuit on March 24, 2025, resulted in a defendant win outcome. The case concerns the patentability of a method for treating a patient with a "disease or condition" usi...
CaseLawBrief currently tracks 5 patentability of diagnostic and treatment methods cases from Federal Circuit. This number is updated as new opinions are published.
Outcome breakdown: Defendant Win: 5.
Each case page on CaseLawBrief includes an AI-generated plain English summary, key holdings, and legal analysis. Click any case above to read its full analysis.